EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 3.0

Conversion Surgery After HAIC-Based Combination Therapy with Targeted Therapy and Immune Checkpoint Inhibitors for Initially Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study

Xiaolong Zhang, Jun Hu iD, Haoming Lan, Xianfeng Shen, Meng Zhou, Youyou Tian

Journal of Hepatocellular Carcinoma · 2026-10 · Volume 13 · 1-13

DOI: 10.2147/jhc.s644129 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-10. Verfasst von Xiaolong Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

conversion surgeryhepatic arterial infusion chemotherapyhepatocellular carcinomaimmortal time biasimmunotherapypathological complete response

Autor:innen und Institutionen

  • Department of Radiology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.
  • Department of Hepatopancreatobiliary Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.
  • Department of Outpatient, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.

ORCID-Profile: Jun Hu

Zitieren

APA

Zhang, X., Hu, J., Lan, H., Shen, X., Zhou, M., & Tian, Y. (2026). Conversion Surgery After HAIC-Based Combination Therapy with Targeted Therapy and Immune Checkpoint Inhibitors for Initially Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study. Journal of Hepatocellular Carcinoma, Volume 13, 1-13. https://doi.org/10.2147/jhc.s644129

Vancouver

Zhang X, Hu J, Lan H, Shen X, Zhou M, Tian Y. Conversion Surgery After HAIC-Based Combination Therapy with Targeted Therapy and Immune Checkpoint Inhibitors for Initially Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-13. doi:10.2147/jhc.s644129

BibTeX
@article{Zhang2026,
  author = {Zhang, Xiaolong and Hu, Jun and Lan, Haoming and Shen, Xianfeng and Zhou, Meng and Tian, Youyou},
  title = {Conversion Surgery After HAIC-Based Combination Therapy with Targeted Therapy and Immune Checkpoint Inhibitors for Initially Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--13},
  doi = {10.2147/jhc.s644129}
}
Kostenlos starten →